Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
Another Patent Dispute Emerges: Small Biotech Firm Sues Moderna, Pfizer, and BioNTech Over COVID-19 Vaccine Tech
June 07, 2023
From Benzinga
From Benzinga
BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5 Cases
May 25, 2023
From Benzinga
From Benzinga
From Benzinga
European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals
May 01, 2023
From Benzinga
Why AstraZeneca Shares Are Trading Higher Today?
April 18, 2023
From Benzinga
FDA Gives Green Signal To Second Omicron-Adapted Booster Shots For People At High Risk From Covid
April 18, 2023
From Benzinga
Long COVID-Fatigue Impacts 50M People - Axcella Health Seeks Funding To Support Drug Development
April 14, 2023
Tickers
AXLA
From Benzinga
EXCLUSIVE: Tiziana Life Sciences Plans To Develop Multiple Sclerosis Hopeful For Long COVID Patients
April 13, 2023
Tickers
TLSA
From Benzinga
US Court Favors Moderna In COVID-19 Vaccine Patent Infringement Case With Arbutus Biopharma
April 12, 2023
From Benzinga
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
April 11, 2023
From Benzinga
Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots
April 04, 2023
From Benzinga
After Denying Earlier, Pfizer & Merck Marginally Cut Prices For COVID-19 Treatments In China
April 04, 2023
From Benzinga
Additional COVID-19 Booster Shots? Officials Anticipate FDA Authorization Within Few Weeks
March 21, 2023
From Benzinga
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
March 21, 2023
From Benzinga
From Benzinga
FDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home Test
March 10, 2023
From Benzinga
FDA's Regulatory Delay is The Reason For Novavax, Lucira Health's Failure: WSJ Report
March 07, 2023
From Benzinga
How Much Did US Government Spend On mRNA Vaccine Technology Before And During The Pandemic? The Number Can Be Surprising
March 03, 2023
From Benzinga
European Commission Keeps Mum On Talks Regarding Pfizer COVID-19 Vaccine Contract: Report
March 02, 2023
From Benzinga
From Benzinga
Oragenics Looks To Boost Potency Of Its Nasal COVID-19 Vaccine With New Licensing Pact
March 01, 2023
Tickers
OGEN
From Benzinga
Pfizer/BioNTech Seek Expanded Approval For Its Updated COVID-19 Shot As Primary Series Vaccination
February 24, 2023
From Benzinga
European Authority Recommends Against Approval For Merck-Ridgeback Biotherapeutics' COVID-19 Pill
February 24, 2023
Tickers
MRK
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.